Abstract:A wide variety of autocrine/paracrine bioactive signals are able to modulate corticosteroid secretion in the human adrenal gland. These regulatory factors, released in the vicinity of adrenocortical cells by diverse cell types comprising chromaffin cells, nerve terminals, cells of the immune system, endothelial cells, and adipocytes, include neuropeptides, biogenic amines, and cytokines. A growing body of evidence now suggests that paracrine mechanisms may also play an important role in the physiopathology of … Show more
“…The third steroid, 17-OHP, having an elevated response to ACTH in the carriers of c5 haplotypes, is the substrate of the steroid 21-hydroxylase enzyme and the enzyme is functionally unidirectional [1], hence the direct effect of CYP21A2 haplotypes hardly explain the elevated 17-OHP response. We hypothesize that the paracrine regulation of adrenal steroidogenesis [35], either directly or indirectly activated by higher cortisol response may the mediate elevated 17-OHP response, and, in fact, an intraadrenal positive regulatory loop exerted by cortisol is observed in some cases [36].…”
PurposeSystematic evaluation of the potential relationship between the common genetic variants of CYP21A2 and hormone levels.MethodsThe relationships of CYP21A2 intron 2 polymorphisms and haplotypes with diverse baseline and stimulated blood hormone levels were studied in 106 subjects with non-functioning adrenal incidentaloma (NFAI). The rationale for using NFAI subjects is dual: i) their baseline hormone profiles do not differ from those of healthy subjects and ii) hormone levels after stimulation tests are available.ResultsThe carriers (N = 27) of a well-defined CYP21A2 haplotype cluster (c5) had significantly elevated levels of cortisol (p = 0.0110), and 17-hydroxyprogesterone (p = 0.0001) after ACTH stimulation, and 11-deoxycortisol after metyrapone administration (p = 0.0017), but the hormone values were in normal ranges. In addition, the carriers (N = 33) of the C allele of the rs6462 polymorphism had a higher baseline aldosterone level (p = 0.0006). The prevalence of these genetic variants of CYP21A2 did not differ between NFAI and healthy subjects.ConclusionsThe common CYP21A2 variants presumably exert the same effect on hormone levels in the healthy and disease-affected populations. Therefore, they may contribute to complex diseases such as some cardiovascular diseases, and may influence the genotype-phenotype correlation in patients with congenital adrenal hyperplasia (CAH) including the individual need for hormone substitution.
“…The third steroid, 17-OHP, having an elevated response to ACTH in the carriers of c5 haplotypes, is the substrate of the steroid 21-hydroxylase enzyme and the enzyme is functionally unidirectional [1], hence the direct effect of CYP21A2 haplotypes hardly explain the elevated 17-OHP response. We hypothesize that the paracrine regulation of adrenal steroidogenesis [35], either directly or indirectly activated by higher cortisol response may the mediate elevated 17-OHP response, and, in fact, an intraadrenal positive regulatory loop exerted by cortisol is observed in some cases [36].…”
PurposeSystematic evaluation of the potential relationship between the common genetic variants of CYP21A2 and hormone levels.MethodsThe relationships of CYP21A2 intron 2 polymorphisms and haplotypes with diverse baseline and stimulated blood hormone levels were studied in 106 subjects with non-functioning adrenal incidentaloma (NFAI). The rationale for using NFAI subjects is dual: i) their baseline hormone profiles do not differ from those of healthy subjects and ii) hormone levels after stimulation tests are available.ResultsThe carriers (N = 27) of a well-defined CYP21A2 haplotype cluster (c5) had significantly elevated levels of cortisol (p = 0.0110), and 17-hydroxyprogesterone (p = 0.0001) after ACTH stimulation, and 11-deoxycortisol after metyrapone administration (p = 0.0017), but the hormone values were in normal ranges. In addition, the carriers (N = 33) of the C allele of the rs6462 polymorphism had a higher baseline aldosterone level (p = 0.0006). The prevalence of these genetic variants of CYP21A2 did not differ between NFAI and healthy subjects.ConclusionsThe common CYP21A2 variants presumably exert the same effect on hormone levels in the healthy and disease-affected populations. Therefore, they may contribute to complex diseases such as some cardiovascular diseases, and may influence the genotype-phenotype correlation in patients with congenital adrenal hyperplasia (CAH) including the individual need for hormone substitution.
“…Additional work indicated that PMAH tissues also produce serotonin, vasopressin, glucagon, and other factors that further contribute to the paracrine regulatory loops of cortisol secretion and cell proliferation (Lefebvre et al 2013). These findings bolster the proposal that paracrine adrenal production of ACTH is central to the cortisol-facilitated regulation of PMAH.…”
Section: Ectopic Expression Of Corticotropin In Pmahmentioning
ACTH-independent macronodular adrenal hyperplasia is a rare cause of Cushing's syndrome (CS), accounting for !2% of all endogenous CS cases; however it is more frequently identified incidentally with sub-clinical cortisol secretion. Recently, cortisol secretion has been shown to be regulated by ectopic corticotropin, which is in turn produced by clusters of steroidogenic cells of the hyperplastic adrenal nodules. Hence, the term 'ACTH-independent' is not entirely appropriate for this disorder. Accordingly, the disease is designated primary macronodular adrenal hyperplasia (PMAH) in this review article. The means by which cortisol production is regulated in PMAH despite the suppressed levels of ACTH of pituitary origin is exceedingly complex. Several molecular events have been proposed to explain the enhanced cortisol secretion, increased cell proliferation, and nodule formation in PMAH. Nonetheless, the precise sequence of events and the molecular mechanisms underlying this condition remain unclear. The purpose of this review is therefore to present new insights on the molecular and genetic profile of PMAH pathophysiology, and to discuss the implications for disease progression.
“…Therefore, an increase in [Ca 2+ ] i is an initiator of apoptosis in V. vulnificus B2 infection. Ca 2+ regulates many signaling pathways such as protein kinase C (PKC), extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), which can mediate apoptosis [37,38]. We found that m-Tor and STAT3 signaling pathway were involved in DC apoptosis induced by V. vulnificus B2, where m-Tor expression was inhibited, while p-STAT-727 expression was activated, eventually downregulating Bcl-2 expression.…”
Background/Aims: Vibrio vulnificus (V. vulnificus) is a Gram-negative marine bacterium that can cause life-threatening primary septicemia, especially in the innate immune system. But how V. vulnificus affects and acts on dendritic cells (DC) is not well understood. The aim of the present study is to investigate [Ca2+]i change and the expression of the mTor-STAT3-Bcl-2 signaling pathway in V. vulnificus B2-induced DC apoptosis, and explore the protective effect of ethylenediaminetetraacetic acid (EDTA) against DC apoptosis in a V. vulnificus B2 and DC2.4 cell coculture infection model, using EDTA as an intervenient. Methods: The apoptosis rate, [Ca2+]i, and the expression of STAT3, m-Tor and Bcl-2 were detected by cytometry, Fluo-8-AM and Western blotting respectively. Results: The results demonstrated that EDTA inhibited the increase of [Ca2+]i, upregulated the expression of m-Tor-STAT3-Bcl-2 signaling pathway, and protected DC against V. vulnificus B2-induced apoptosis. Conclusions: EDTA inhibits V. Vulnificus-induced DC apoptosis by lowering [Ca2+]i via m-Tor-STAT3-Bcl-2 signaling pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.